Soractelite
  • Home
  • Benign Prostatic Hyperplasia
  • SoracteLite
    • Non surgical treatment
    • Testimonials
    • FAQ
  • News
  • Company
  • Contact Us
  • English
    • Italian
Select Page
Prostate: the micro-invasive solution for prostate BPH

Prostate: the micro-invasive solution for prostate BPH

Jul 27, 2017

Strettoweb.com Read the article here

read more
Clinica San Michele – Maddaloni, SoracteLite presented at the convention on technological innovation on prostate BPH treatments

Clinica San Michele – Maddaloni, SoracteLite presented at the convention on technological innovation on prostate BPH treatments

Jul 25, 2017

CasertaNews.it Read the articlehere

read more
Alzano, Pesenti Fenaroli Hospital: Laser treatment for BPH presented to Chinese Doctors

Alzano, Pesenti Fenaroli Hospital: Laser treatment for BPH presented to Chinese Doctors

May 23, 2017

Bergamo News Read the article here

read more
Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study.

Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study.

May 8, 2017

UroToday Read the article here

read more
Next Entries »

Search

Archive

  • August 2025
  • July 2025
  • September 2024
  • April 2024
  • March 2024
  • February 2024
  • December 2023
  • November 2023
  • April 2023
  • March 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • June 2022
  • May 2022
  • March 2022
  • February 2022
  • January 2022
  • November 2021
  • August 2021
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • March 2020
  • January 2020
  • December 2019
  • November 2019
  • August 2019
  • March 2019
  • October 2018
  • September 2018
  • May 2018
  • April 2018
  • November 2017
  • September 2017
  • July 2017
  • May 2017
  • Legal Notes
  • Privacy and Cookies Policy
  • Information for Customers and Suppliers

REGULATORY NOTICE USA

EchoLaser X4 is FDA cleared (510K) for tissue ablation in urology. Indications for use are however not disease specific. Although there’s solid clinical evidence, generated by a multitude of published clinical trials, confirming safety and efficacy of the treatment, patients must always discuss treatment options with a specialist doctor. It will ultimately be the specialist doctor who will determine if a patient is eligible for EchoLaser treatment.

© 2018 SoracteLite is a registered trademark in European Union by: Elesta SpA – tel.+39 055 88 26 807 – fax.+39 055 7766698
info@elesta-echolaser.com

The information published in this website is of general nature and only have an informative purpose. Under no circumstances can they replace any treatment or therapy prescribed by a physician or other healthcare professionals authorised by law. Any information on medical procedures and treatment descriptions in this website are intended for informative purposes only and do not provide the knowledge required for their application. All the indications provided at www.soractelite.info must always be backed up by the opinion of your doctor.

This site uses cookies to provide you with a better browsing experience. By accepting this banner, scrolling down this page, clicking on a link or continuing to browse in any other way, you consent to the use of cookies. If want to know more read our cookie policy.